Antibacterial and Antivirulence Activity of Glucocorticoid PYED-1 against Stenotrophomonas maltophilia

Antibiotics
Anna EspositoEliana De Gregorio

Abstract

Stenotrophomonas maltophilia, an environmental Gram-negative bacterium, is an emerging nosocomial opportunistic pathogen that causes life-threatening infections in immunocompromised patients and chronic pulmonary infections in cystic fibrosis patients. Due to increasing resistance to multiple classes of antibiotics, S. maltophilia infections are difficult to treat successfully. This makes the search for new antimicrobial strategies mandatory. In this study, the antibacterial activity of the heterocyclic corticosteroid deflazacort and several of its synthetic precursors was tested against S. maltophilia. All compounds were not active against standard strain S. maltophilia K279a. The compound PYED-1 (pregnadiene-11-hydroxy-16α,17α-epoxy-3,20-dione-1) showed a weak effect against some S. maltophilia clinical isolates, but exhibited a synergistic effect with aminoglycosides. PYED-1 at sub-inhibitory concentrations decreased S. maltophilia biofilm formation. Quantitative real-time polymerase chain reaction (RT-qPCR) analysis demonstrated that the expression of biofilm- and virulence- associated genes (StmPr1, StmPr3, sphB, smeZ, bfmA, fsnR) was significantly suppressed after PYED-1 treatment. Interestingly, PYED-1 also repressed the...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Oct 24, 2002·The Journal of Hospital Infection·M CrispinoR Zarrilli
Aug 17, 2004·Infectious Disease Clinics of North America·Matthew E Levison
Feb 9, 2005·Diagnostic Microbiology and Infectious Disease·Evangelos J Giamarellos-BourboulisHelen Giamarellou
Sep 21, 2007·International Journal of Immunopathology and Pharmacology·G Di BonaventuraB Colonna
Nov 22, 2007·Advances in Therapy·Oscar Gonzalez-PerezCesar Ramos-Remus
Apr 28, 2009·The Lancet Infectious Diseases·W John LooneyKathrin Mühlemann
Jun 10, 2010·FEMS Microbiology Letters·Francesco RoccoPier Paolo Di Nocera
Oct 19, 2010·International Journal of Medical Microbiology : IJMM·Mauro NicolettiMariassunta Casalino
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
Jan 9, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Valerie WatersFelix Ratjen
Aug 2, 2013·BMC Genomics·Pier Paolo Di NoceraFrancesco Rocco
Feb 21, 2014·British Journal of Clinical Pharmacology·Begoña HerasJennifer L Martin
Jul 16, 2015·Frontiers in Microbiology·María B Sánchez
Dec 17, 2015·Letters in Applied Microbiology·M MartinucciE De Gregorio
May 18, 2016·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Erlin SunWei Qi
Aug 18, 2017·Pediatric Pulmonology·Emily E BarskyGregory S Sawicki
May 5, 2018·International Journal of Medical Sciences·Hye-Rim KimYong-Bin Eom
Jul 19, 2018·Current Microbiology·Eliana De GregorioPier Paolo Di Nocera
Aug 15, 2018·BioMed Research International·Arunkumar KarunanidhiVasanthakumari Neela
Nov 14, 2018·Infectious Diseases·Angelina Trifonova, Tanya Strateva
Feb 12, 2019·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Freddy FrostMartin J Walshaw
Oct 30, 2019·Expert Review of Anti-infective Therapy·Samantha Flores-TreviñoElvira Garza-González

❮ Previous
Next ❯

Citations

Jan 21, 2021·Future Microbiology·Bárbara Ellen Santos CarvalhaisKênia Valéria Dos Santos
May 28, 2021·Clinical Microbiology Reviews·Joanna S Brooke

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Wei-Sheng WangFu-Yuan Huang
American Journal of Respiratory and Critical Care Medicine
Valerie J WatersFelix Ratjen
© 2021 Meta ULC. All rights reserved